In murine malaria, prolonged PTH treatment has been shown to prevent infection-induced proliferation of hematopoietic stem cells (HSCs), partially preserve osteoblasts, and lower global IFN-γ levels by reducing the number of IFN-γ-secreting T cells [92]. This evidence concerns the gene IFNG and malaria.